Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome

What is it about?

ARDS biological heterogeneity is a big obstacle in the clinical translation of pharmacological interventions. Analysis of metabolic alterations can inform development of therapeutics aimed at the ARDS subpopulations and highlights mitochondrial dysfunction as a potential therapeutic target.

Featured Image